Introduction {#S1}
============

Subterranean animals offer an excellent opportunity to study morphological, molecular and physiological changes that allow organisms to adapt to unique environments. Loss of eyes is one of the most common morphological features of cave-adapted animals, including many fish species. Blind cave fish (CF) morphs of *Astyanax mexicanus* evolved from surface fish (SF) during a few million years of isolation in dark Mexican caves^[@R1]^, with recent studies suggesting that regression of eyes evolved as part of a strategy to conserve energy in fish adapted to dark and nutrient deficient caves^[@R2]^. Although a number of studies have examined molecular mechanisms underlying eye loss in Pachón cave-derived *Astyanax mexicanus* CF, recent sequencing of the Pachón CF genome and other studies revealed no inactivating null mutations in essential eye development genes^[@R3]-[@R7]^. In contrast, genome sequencing of another subterranean animal, the naked mole rat *Heterocephalus glaber*, showed combined functional loss of more than a dozen key eye genes due to inactivating mutations^[@R8]^. The absence of obvious null mutations in essential eye genes despite dramatic effects on eye development suggests the possibility that Pachón cavefish might harbor cis-regulatory mutations in causing altered expression of eye genes and epigenetic regulators, and most likely the epigenetic regulation indirectly affecting the expression of large numbers of target eye genes at the same time. DNA methylation is one such epigenetic mechanism which is known to be able to simultaneously alter the expression of large cohorts of genes^[@R9]^. To test the possibility that altered DNA methylation plays a role in Pachón cave fish eye loss, we used CF and SF morphs of *Astyanax mexicanus* as well as wild type and DNA methylation and demethylation-deficient zebrafish *Danio rerio* to examine whether DNA methylation regulates eye formation, and whether eye loss in Pachón cave fish evolved at least in part through hypermethylation of key eye genes.

Results and Discussion {#S2}
======================

At 36 hpf *Astyanax mexicanus* CF and SF embryos are superficially indistinguishable with properly formed lenses and optic cups in both morphs ([Fig. 1a,b](#F1){ref-type="fig"}). By five days of development, however, degeneration of eye tissue is clearly evident ([Fig. 1c,d](#F1){ref-type="fig"}), and by adulthood CF eyes are completely absent ([Fig. 1e,f](#F1){ref-type="fig"})^[@R10]^. Eye regression is preceded by decreased expression of a number of different eye-specific genes, including the crystallins *crybb1, crybb1c*, and *cryaa* ([Fig. 1g](#F1){ref-type="fig"}). The expression of large sets of genes can be repressed by DNA methylation based epigenetic silencing, as perhaps most famously shown for X chromosome inactivation^[@R11]^. New epigenetic DNA methyl "marks" are added by specific enzymes known as *de novo* DNA methyltransferases (DNMTs)^[@R12]^, and we recently showed that one of these enzymes, *dnmt3bb.1*, is expressed in zebrafish hematopoietic stem and progenitor cells (HSPC) where its loss leads to failure to maintain HSPCs^[@R13]^. We found that *dnmt3bb.1* is also expressed in the ciliary marginal zone (CMZ) of the developing eye, a specialized stem cell-containing tissue surrounding the lens that is responsible for generating neurons and other eye cell types^[@R14]-[@R16]^ ([Fig. 1h](#F1){ref-type="fig"}). In addition to their hematopoietic defects *dnmt3bb.1^y258^* null mutant larvae and adults have enlarged eyes compared to their wild type (WT) siblings ([Fig. 1i-k](#F1){ref-type="fig"}) with retinal hyperplasia ([Supplementary Fig. 1](#SD2){ref-type="supplementary-material"}), and increased expression of a number of different eye genes, including *opn1lw1, gnb3a*, and *crx* ([Fig. 1l](#F1){ref-type="fig"}). Interestingly, the closely related *Astyanax mexicanus dnmt3bb.1* gene, which also maps to an eye size QTL^[@R6]^, shows 1.5-fold increased expression in Pachón CF compared to SF ([Fig. 1m](#F1){ref-type="fig"} and [Supplementary Fig. 2](#SD2){ref-type="supplementary-material"}). The inverse correlation between eye size and *dnmt3bb.1* expression in *Danio rerio* and *Astyanax mexicanus* led us to hypothesize that excessive Dnmt3bb.1-dependent methylation may globally repress expression of eye genes in CF.

To more comprehensively examine whether increased DNA methylation correlates with reduced eye gene expression in CF versus SF, we performed combined RNAseq and whole genome bisulfite sequencing on RNA and DNA simultaneously co-isolated from 54 hpf CF or SF eyes, during a critical period for eye development in Pachón CF^[@R10]^ ([Fig. 2a](#F2){ref-type="fig"}). RNAseq analysis confirmed increased expression of *dnmt3bb.1* in CF eyes ([Fig. 2b,c](#F2){ref-type="fig"}). The RNAseq data also revealed that a large number of different eye development genes show reduced expression in CF eyes ([Fig. 2c](#F2){ref-type="fig"} and [Supplementary data 1](#SD2){ref-type="supplementary-material"}). As in the naked mole rat, visual perception (GO:0007601) and electrophysiology of eye are the top down-regulated biological processes found using Gene Ontology (GO) ([Fig. 2d](#F2){ref-type="fig"}) and Ingenuity Pathway Analysis ([Supplementary Fig. 3](#SD2){ref-type="supplementary-material"}), respectively. Ingenuity pathway analysis also predicted that the phototransduction pathway is the most affected signaling pathway in cavefish eyes compared to surface eyes ([Supplementary Fig. 3](#SD2){ref-type="supplementary-material"}).

Previous studies have shown that promoter methylation is highly correlated with gene repression^[@R17]^. One hundred and twenty-eight genes show substantially increased methylation within the 2 Kb of genomic DNA upstream from the transcriptional start site in CF versus SF (≥ 15% increase, p ≤ 0.05) and decreased expression in CF eyes compared to SF eyes (fold decrease ≤ 1.5, p ≤ 0.05) ([Supplementary data 2](#SD2){ref-type="supplementary-material"}). These include 39 and 26 genes annotated as having eye expression in mice and humans respectively ([Supplementary data 3](#SD2){ref-type="supplementary-material"}). Interestingly, nineteen of these genes have been previous linked to human eye disorders ([Table 1](#T1){ref-type="table"}). These include *opn1lw1*, an opsin associated with cone-rod dystrophy and colorblindness^[@R18],[@R19]^, *gnb3a*, defective in autosomal recessive congenital stationary night blindness^[@R20],[@R21]^, and *crx*, a photoreceptor-specific transcription factor whose loss leads to blindness in humans^[@R22],[@R23]^. Targeted bisulfite sequencing of DNA amplified from the *opn1lw1, gnb3a*, and *crx* promoter regions from 54 hpf SF or CF eyes confirms increased methylation of CpGs in the 5' upstream sequences of each of these three genes ([Fig. 2e,g,i,k,m,o](#F2){ref-type="fig"}, [Supplementary Fig. 4](#SD2){ref-type="supplementary-material"}). Whole mount *in situ* hybridization using *opn1lw1, gnb3a*, and *crx* probes also verifies strongly decreased expression of the three genes in CF versus SF eyes ([Fig. 2f,h,j,l,n,p](#F2){ref-type="fig"}). Together, these data show that expression of key human eye disease-associated eye development genes is reduced in Pachón CF compared to their SF relatives, and that many of these eye genes also display increased promoter methylation. Interestingly, the *crx* transcription factor is itself necessary for proper expression of a large number of additional eye genes^[@R23]^, many of which are also strongly reduced in CF eyes, even though most of these genes are not themselves methylated ([Supplementary Fig. 5](#SD2){ref-type="supplementary-material"}).

Increased expression of eye genes such as *opn1lw1, gnb3a*, and *crx* ([Fig. 1l](#F1){ref-type="fig"}) and increased eye size ([Fig. 1m](#F1){ref-type="fig"}) in *dnmt3bb.1* mutant zebrafish is consistent with the hypothesis that DNA methylation represses eye gene expression to restrain or limit eye development. To experimentally test this idea, we examined whether increasing DNA methylation levels results in decreased eye gene expression and reduced eye development, using previously described zebrafish *Ten-eleven translocation methylcytosine dioxygenase (TET)* mutants that display global DNA hypermethylation^[@R24]^. Unlike DNMTs, which add methyl groups to cytosines to generate 5-methylcytosine, TET proteins oxidize methylcytosine to hydroxyl-methylcytosine, promoting DNA demethylation^[@R25],[@R26]^. Like mammals, zebrafish have three TET enzymes with partially redundant functions, Tet1, Tet2, and Tet3. Tet2 and Tet3 are the main TET proteins responsible for converting methylcytosine into hydroxymethylcytosine; zebrafish *tet1^-/-^, tet2^-/-^, tet3^-/-^* triple mutants do not show additional phenotypes compared to *tet2^-/-^, tet3^-/-^* double mutants^[@R24]^. We found that *tet2^-/-^, tet3^-/-^* double mutants have smaller eyes than their wild type siblings ([Fig. 3a-c](#F3){ref-type="fig"}). Targeted bisulfite sequencing and qRT-PCR on nucleic acids from whole eyes dissected from 48 hpf *tet2^-/-^, tet3^-/-^* double mutants and their wild type siblings also revealed increased *crx* and *gnb3a* promoter methylation ([Fig. 3d-g](#F3){ref-type="fig"}, [Supplementary Fig. 6](#SD2){ref-type="supplementary-material"}) and reduced *crx* and *gnb3a* gene expression ([Fig. 3h](#F3){ref-type="fig"}) in the double mutants. Like *dnmt3bb.1* mutants, *tet2^-/-^, tet3^-/-^* double mutants also show hematopoietic defects. In addition, after 48 hpf *tet2^-/-^, tet3^-/-^* double mutants begin to deteriorate with defects in brain development and do not survive beyond 5 dpf. These additional phenotypes may arise as a result of global DNA hypermethylation in these mutants.

To further test whether excess DNA methylation contributes to failure to maintain eye development in Pachón CF, we examined whether eye loss could be "rescued" by pharmacological inhibition of DNA methylation. 5-Azacytidine (Aza) is a well-characterized inhibitor of DNA methylation^[@R27]^ approved for treatment of aberrant DNA methylation in myelodysplastic syndrome patients^[@R28]^. Since systemic administration of Aza to zebrafish embryos leads to severe pleiotropic defects and early lethality^[@R29]^, we carried out single injections of either Aza or control DMSO carrier into the vitreous chamber of the left eye of 42-48 hpf CF embryos, and then scored phenotypes in both injected left and control right eyes at 5 days post fertilization ([Fig. 4a](#F4){ref-type="fig"}). A single early injection of Aza into the left eye resulted in larger eyes than either the control uninjected right eyes in the same animals or the DMSO-injected left eyes of other animals ([Fig. 4b](#F4){ref-type="fig"}). Histological analysis confirmed that Aza-injected 5 dpf CF eyes are significantly larger than uninjected or DMSO injected controls, and that they possess a more organized structure including morphologically well defined lens and retinal layers ([Fig. 4c-e](#F4){ref-type="fig"}). Targeted promoter bisulfite sequencing of *gnb3a* from Aza-injected cavefish eyes revealed reduced DNA methylation at this locus ([Supplementary Fig. 7A](#SD2){ref-type="supplementary-material"}). Increased expression of *gnb3a* and *crx* was also noted in cavefish eyes injected with either Aza or the more "DNA specific" drug 5-aza-2-deoxycytidine (Aza-D) ([Supplementary Fig. 7B](#SD2){ref-type="supplementary-material"}), suggesting that either inhibiting the excess methylation of eye genes in cavefish results in increased expression of these genes and at least a partial "rescue" of eye development.

Together, our results suggest that DNA methylation plays a critical role in teleost eye development, and that increased DNA methylation-based eye gene repression is a major molecular mechanism underlying CF eye degeneration ([Fig. 4f](#F4){ref-type="fig"}). Many of the key eye genes down-regulated in cave fish are conserved in humans and linked to eye disease and/or blindness, suggesting potential conserved function for these genes across evolution. Although a central role for DNA methylation in development and disease has been well-documented^[@R30],[@R31]^, our results suggest that small genetic changes that alter epigenetic regulation can play an important role in rapid adaptive evolution by triggering dramatic changes in the expression of large sets of genes. There is precedent for epigenetic changes resulting in dramatically altered developmental fates; for example, nutrition-driven changes in DNA methylation regulate the switch between queen and worker caste specification in honey bees (*Apis mellifera*)^[@R32]^. Our findings indicate that eye loss in Pachón cavefish occurs via distinct molecular mechanisms compared to naked mole rats, where inactivating mutations are found in multiple key eye genes. This could reflect differences in their evolutionary timescales. Cavefish evolved over the past one to five million years^[@R1]^, while naked mole rats evolved seventy-three million years ago^[@R8]^, allowing sufficient time to fix and select acquired mutations in genes essential for eye development. It remains to be seen whether altered epigenetic regulation has been used to generate phenotypic variability in other rapidly evolved animals.

Methods {#S4}
=======

Fish stocks and embryos {#S5}
-----------------------

Zebrafish lines used in this study include *dnmt3bb.1^y258^* (Ref. [@R13]) and *tet2^mk17^, tet3^mk18^* (Ref. [@R13]) mutants and the EK wild type line. Surface and Pachon cave populations of *Astyanax mexicanus* are used in this study. Fish were spawned naturally and embryos were raised and staged as described previously^[@R33],[@R34]^. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (12-039 and 18-016) of the National institute of child health and human development.

Genomic DNA isolation, bisulfite conversion, and sequencing {#S6}
-----------------------------------------------------------

Surface and cavefish embryos were raised to described stages. Dechorionated embryos were transferred into 1X PBS without calcium and magnesium. Eyes were surgically removed using a pair of fine tip tungsten needles. Total cellular RNA and DNA was isolated from harvested eyes using ZR Duet DNA/RNA miniprep kit (Zymo Research). For whole genome bisulfite sequencing, 200 ng of purified genomic DNA was bisulfite converted using EZ DNA methylation-Lightning kit (Zymo research). Next Gen sequencing libraries were generated from the bisulfite converted DNA using TruSeq DNA methylation kit and TruSeq DNA methylation Index PCR primers (Illumina). Sequencing libraries of two biological replicates from surface and cavefish were run separately on two FlowCells of an Illumina HiSeq2500 sequencer operated in the RapidRun mode with V2 chemistry to yield about 400 million read pair reads (2 × 100bp) for each sample. Raw single-end sequence data was trimmed for quality and adapter sequence using Trimmomatic software, trimming leading or trailing bases at quality \< 5 as well as using a sliding window requiring a 4 bp average of quality \> 15. Reads trimmed below 50 bp were discarded. Following trimming, reads were aligned using Bismark software against a bisulfite converted Pachon cavefish genome using non-directional alignment. Using defined gene coordinates, gene body and promoter -2kb of TSS regions were assigned and combined conversions and non-conversions were summed to provide an overall bisulfite conversion rate per region. The ratio of conversions was then tested for change between conditions using a two-proportion z-test testing the hypothesis that the proportion of bisulfite conversion had altered between conditions. For targeted bisulfite analysis, bisulfite converted DNA was PCR amplified using primers designed by MethPrimer^[@R35]^ (<http://www.urogene.org/cgi-bin/methprimer/methprimer.cgi>). One Taq Hotstart 2X master mix in standard buffer DNA polymerase (NEB) was used to amplify bisulfite converted DNA. PCR amplicons were purified and cloned using pCRII-TOPO TA cloning kit (Thermofisher). Miniprep plasmid DNA was sequenced using T7 or SP6 sequencing primers. Sequencing results were analyzed using QUMA^[@R36]^ (<http://quma.cdb.riken.jp/>).

RNA isolation and sequencing {#S7}
----------------------------

Total cellular RNA and DNA was isolated from the harvested eyes using ZR Duet DNA/RNA miniprep kit (Zymo Research). 300-900ng poly-A enriched RNA was converted to indexed sequencing libraries using the TruSeq Standard mRNA library prep kit (Illumina). Libraries for two biological replicates of surface and cavefish were combined and run on one FlowCell of an Illumina HiSeq 2500 sequencer in RapidRun mode with V2 chemistry. 100 million read pairs (2 × 100) per sample were sequenced. Paired-end reads were trimmed using trimmomatic and aligned to Pachon cavefish genome using RNA-STAR, quantitation performed with subread feature Counts and differential expression analysis performed with count data via DESeq2. Human, mouse and zebrafish homologs of cavefish genes were identified using Ensembl BioMart. Ingenuity pathway and Panther GO term enrichment analyses were carried out on RNA sequencing data to identify major signaling pathways and networks affected based on differentially expressed genes.

RNA isolation, cDNA synthesis and qRT-PCR {#S8}
-----------------------------------------

Total cellular RNA was isolated from harvested eyes and other tissues as mentioned in the text using ZR Duet DNA/RNA miniprep kit (Zymo Research). Equal amounts of RNA were converted into cDNA using the ThermoScript RT-PCR system (Invitrogen). Resulting cDNA was used in qPCR using SsoAdvanced™ Universal SYBR® Green Supermix (Biorad) on a CFX96 Real Time system. A minimum of three biological replicates were performed. Primers used in this study are listed in [Supplementary Data 4](#SD2){ref-type="supplementary-material"}.

Riboprobe synthesis, *In situ* hybridizations and histology {#S9}
-----------------------------------------------------------

Antisense riboprobes were generated using Roche DIG and FITC labeling mix. Portions of the coding regions of genes were PCR amplified using One Taq Hotstart 2X master mix in standard buffer DNA polymerase (NEB) and cloned into pCRII-TOPO TA vector (Thermofisher). Sequence verified clones were used to generate antisense riboprobes using appropriate enzymes. The zebrafish *dnmt3bb.1* probe was generated as described previously^[@R13]^. Whole mount *in situ* hybridization was carried out as described previously with a few modifications. To reduce non-specific hybridization and enhance signal to noise ratio we used 5% dextran sulfate (Sigma) in the hybridization buffer and pre-adsorbed anti-DIG and anti-FITC antibodies to whole cavefish powder. For histology, embryos and tissue samples were fixed using 4% para-formaldehyde overnight at 4°C and subsequently passed through ascending grades of alcohol followed by paraffin embedding. Sections were stained using hematoxylin and eosin (H&E).

Microinjection {#S10}
--------------

Microinjection of 5-Azacytidine or 5-Aza-2'-deoxycytidine (Sigma) into Pachon cavefish embryonic eyes was carried out at 42-48 hpf embryos. Embryos were mounted laterally in low melting point agarose. Injection needles were pulled from filament-containing glass capillaries (World Precision Instruments Cat. No. TW100F-4) using a needle puller (Sutter Instruments). Needles were back loaded and a single 1-2 nl bolus of either 100μM 5-Azacytidine or 5-Aza-2'-deoxycytidine in 5% DMSO or 5% DMSO carrier alone was delivered into the vitreous of the left eye using a Pneumatic Picopump (World Precision Instruments). Embryos were removed from the agarose, allowed to continue to develop until 5 dpf, and then scored for eye size and/or used for histological analysis of the eyes. Injected embryos with axis or brain deformities were discarded from the analysis.

Eye size quantifications {#S11}
------------------------

For eye size measurements, embryos were imaged at same magnifications for mutants, treated and controls. All eye size measurements were performed by normalizing the area of the eyes to the head. Student's t-test (paired) was performed on the normalized eye sizes.
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![Eye phenotypes in *Astyanax mexicanus* surface and cave fish, and in zebrafish *Danio rerio* wild type and *dnmt3bb.1^y258^* mutant animals\
**a-d**, Transmitted light photomicrographs of the heads of 36 hpf (a,b) and 5 dpf (c,d) surface (a,c) and cavefish (b,d) morphs of *A. mexicanus*. Black arrow mark the developing eyes in CF and SF. **e,f**, Photographic images of the heads of adult surface (e, with eyes) and cave (f, eyeless) morphs of *A. mexicanus*. **g**, Quantitative RT-PCR analysis of the percent relative expression of *crybb1, crybb1c, cryaa*, and *myod* in isolated heads from 54 hpf surface (orange columns) and cave (blue columns) morphs of *A. mexicanus*, normalized to surface fish levels. Histograms show mean, error bars represent s.e.m of three biological replicates; two-tailed t-test, \*p\<0.005. **h**, Whole mount *in situ* hybridization of a 36 hpf zebrafish eye probed for *dnmt3bb.1*, showing expression in the ciliary marginal zone (CMZ, arrows). **i,j**, Photographic images of the eyes of adult wild type sibling (i) and *dnmt3bb.1^y258^* mutant (j) zebrafish. **k**, Quantitation of eye size in three week old wild type sibling and *dnmt3bb.1^y258^* mutant animals. Histograms show mean, error bars represent s.d. in the relative eye size (n =18) two-tailed t-test, \*p\<0.05. **l**, Quantitative RT-PCR analysis of the percent relative expression of *opn1lw1, gnb3a*, and *crx* in adult wild type sibling (orange columns) and *dnmt3bb.1^y258^* mutant (blue columns) zebrafish eyes, normalized to wild type sibling levels. Histograms show mean, error bars represent s.e.m of three biological replicates; two-tailed t-test, \*p\<0.005. **m**, Quantitative RT-PCR analysis of the percent relative expression of *dnmt3bb.1* in surface and cave morphs of *A. mexicanus*, normalized to surface fish levels. All images are lateral views, rostral to the left. Histograms show mean, error bars represent s.e.m of three biological replicates, p\<0.05 using t-test. Scale bars 100μM in b for a,b, 250μM in d for c,d, 3mm in e for e,h, 50μM for h and 1mm in j for i,j.](nihms964955f1){#F1}

![Gene expression changes in cave versus surface fish morphs of *Astyanax mexicanus*\
**a**, Diagram showing the workflow for obtaining larval eyes from *A. mexicanus* and for co-isolating eye DNA and RNA for whole genome assessment of DNA methylation and gene expression, respectively. **b**, Percent relative expression of *dnmt3bb.1* in the eyes of *A. mexicanus* cave vs. surface fish morphs by comparison of their respective RNAseq data sets (2-replicates), normalized to surface fish levels, FPKM p\<0.05. **c**, Log2 fold differential expression (p\<0.05) of genes in *A. mexicanus* cave vs. surface fish morph RNAseq data sets, with down-regulated (red) or up-regulated (blue) expression of selected genes in CF noted. **d**, Listing of the Gene Ontology (GO) terms showing the greatest down-regulation in cave fish compared to surface fish. **e-p**, Assessment of *opn1lw1*(e-h), *gnb3a* (i-l), and *crx* (m-p) promoter DNA methylation (e,g,i,k,m,o) and gene expression (f,h,j,l,n,p) in 54 hpf surface (e,f,i,j,m,n) or cave (g,h,k,l,o,p) morphs of *A. mexicanus*. Panels show pie chart graphical representation of the percentage methylation of the promoter CpG (e,g,i,k,m,o), and representative whole mount *in situ* hybridization of the larval heads (f,h,j,l,n,p) using the probes noted (ventral views, rostral up, minimum 20-25 embryos were analyzed by *in situ* hybridization). Scale bar 100μM in p for f,h,j,l,n, and p.](nihms964955f2){#F2}

![Eye phenotype and associated gene expression changes in wild type and DNA methylation-deficient *Danio rerio*\
**a-b**, Transmitted light photomicrographs of the heads of 48 hpf wild type sibling (a) and *tet2^-/-^, tet3^-/-^* double mutant (b) embryos. **c**, Quantitation of eye size in 48 hpf wild type sibling and *tet2^-/-^, tet3^-/-^* double mutant embryos. Histograms show mean, error bars represent s.d. in the relative eye size (n =10), two-tailed t-test, \*p\<0.05. **d-g**, Assessment of *crx* (d,f) and *gnb3a* (e,g), promoter DNA methylation in isolated eyes from 48 hpf wild type sibling (d,e) and *tet2^-/-^, tet3^-/-^* double mutant (f,g) animals. **h**, Quantitative RT-PCR analysis of the percent relative expression of *crx* and *gnb3a* in isolated eyes from 48 hpf wild type sibling (orange columns) and *tet2^-/-^, tet3^-/-^* double mutant (blue columns) animals. Histograms show mean, error bars represent s.e.m of three biological replicates; two-tailed t-test, \*p\<0.005. Scale bar 100μM in b for a and b.](nihms964955f3){#F3}

![Partial rescue of cavefish eyes by AZA-mediated inhibition of eye DNA methylation\
**a**, Schematic diagram showing the experimental procedure for injection of DMSO or AZA into 42-48 hpf cavefish embryo eyes. **b**, Quantitation of eye size in 5 dpf cavefish embryos injected in the left eye with DMSO or AZA. Histograms show mean, error bars represent s.d. in the relative eye size (18 DMSO and 12 Aza injected embryos) two-tailed t-test, \*p\<0.05. **c-e**, Histological analysis of H&E stained 5 dpf surface fish eye (c), DMSO injected cavefish eye (d) and AZA injected cavefish eye (e) (four to eight embryos per condition were sectioned and analyzed by H&E staining). **f**, Model depicting the role of DNA methylation in teleost eye development and degeneration. Hypermethylation and down-regulation of eye gene expression in cavefish and zebrafish *tet^2/3^* double mutants leads to eye degeneration. Scale bar 100μM in a for a-c.](nihms964955f4){#F4}

###### Cavefish genes with significant promoter hypermethylation and reduced expression are associated with human eye disorders

Nineteen genes with both substantially increased methylation within the 2 Kb of genomic DNA upstream from the transcriptional start site (≥ 15% increase, p ≤ 0.05) and substantially decreased gene expression (fold decrease ≤ 1.5, p ≤ 0.05) in CF eyes compared to SF eyes that have also been linked to human eye disorders.

  Eye Gene   Log2 Fold Change in Gene Expression   Change in Promoter Methylation (%)   Associated Human Eye Disease
  ---------- ------------------------------------- ------------------------------------ -------------------------------
  STX3       -2.6545922                            15.0532125                           Microvillus inclusion disease
  IMPG1      -2.0676398                            15.7283333                           Macular dystrophy
  GNB3       -2.1535092                            15.7549858                           Congenital nigh blindness
  RS1        -4.8162527                            16.2271036                           Retinoschisis
  ELOVL4     -2.7387552                            16.9231332                           Stargard disease
  TRPM1      -1.5194777                            17.1153846                           Congenital night blindness
  KCNV2      -2.6133734                            19.2768429                           Retinal cone dystrophy
  HEPACAM    -1.292728                             19.2838136                           Macrocephaly
  CRX        -1.3492741                            20.3620072                           Retinitis pigmentosa
  PDE6H      -2.4364817                            20.8408953                           Retinal cone dystrophy
  PRPH2      -4.6162474                            21.9236441                           Retinitis pigmentosa
  TMEM98     -1.3082467                            23.6850216                           Nanophthalmia
  GRK1       -4.3915902                            24.7866469                           Oguchi disease
  MYO7A      -1.342215                             31.2060616                           Usher syndrome
  ATP6V0A1   -1.4653532                            32.7039627                           Macroautophagy
  TDRD7      -1.8275097                            34.9881388                           Cataract
  OPN1MW     -7.2622181                            36.788428                            Cone rod dystrophy
  CRYGB      -4.1315449                            39.2857143                           Polar cataract
  OPN1LW     -4.1525329                            47.985771                            Cone rod dystrophy
